E-Qure Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EQUR research report →
About the company
E-Qure Corp. , a medical technology firm, is dedicated to the development and distribution of medical devices that utilize bioelectrical signal therapy (BST). These BST devices leverage their exclusive and patented electrical stimulation techniques to address and resolve challenging, difficult-to-heal wounds and ulcers, aiming for their full closure and recovery.
- CEO
- Ohad Goren
- IPO
- 1994
- Employees
- 1
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $6.91K
- P/E
- -0.01
- P/S
- 0.00
- P/B
- -0.02
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 175.41%
- ROIC
- 262.00%
- Revenue
- $0 · 0.00%
- Net Income
- $-577,051 · -30.02%
- EPS
- $-0.02 · -30.47%
- Op Income
- $-647,661
- FCF YoY
- 21.42%
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 1.15
- Avg Volume
- 286
Get TickerSpark's AI analysis on EQUR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 14 | WEISSBERG RON | sell | 62,380 |
Our EQUR coverage
Recent articles, reports, and earnings notes.
No research on EQUR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EQUR report →Similar companies
Peers in the same neighborhood.